Section Arrow
FBLG.NASDAQ
- FibroBiologics Inc.
Quotes are at least 15-min delayed:2026/07/07 15:20 EDT
Regular Hours
Last
 0.86425
-0.00445 (-0.51%)
Day High 
0.8906 
Prev. Close
0.8687 
1-M High
1.04 
Volume 
23.50K 
Bid
0.8501
Ask
0.8784
Day Low
0.85 
Open
0.8906 
1-M Low
0.731 
Market Cap 
4.56M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.83 
20-SMA 0.87 
50-SMA 1.06 
52-W High 14.678 
52-W Low 0.731 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.02/-3.06
Enterprise Value
6.26M
Balance Sheet
Book Value Per Share
0.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CRNXCrinetics Pharmaceuticals83.445+41.415+98.54%-- 
TVRDTvardi Therapeutics Inc3.08+1.07+53.23%-- 
RXRXRecursion Pharmaceuticals3.93-0.03-0.76%-- 
TOVXTheriva Biologics Inc0.2379-0.0154-6.08%-- 
GOSSGossamer Bio0.177-0.0179-9.18%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.